Io Biotech Inc
(IOBT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 95,177 | 91,443 | 71,424 | 41,234 | 10,145 |
| Operating Income | -95,177 | -91,443 | -71,424 | -41,234 | -10,145 |
| Interest Expense | 0 | 0 | 302 | 361 | 26 |
| Other Income | 1,129 | 6,212 | 1,541 | -26,216 | -1,871 |
| Pre-tax Income | -94,048 | -85,231 | -70,185 | -67,811 | -12,042 |
| Income Tax | 1,443 | 852 | 1,273 | 68 | N/A |
| Net Income Continuous | -95,491 | -86,083 | -71,458 | -67,879 | -12,042 |
| Net Income | $-95,491 | $-86,083 | $-71,458 | $-67,879 | $-12,042 |
| EPS Basic Total Ops | -1.45 | -1.98 | -2.48 | -17.30 | -82.36 |
| EPS Basic Continuous Ops | -1.45 | -1.98 | -2.48 | -15.65 | -67.96 |
| EPS Diluted Total Ops | -1.45 | -1.98 | -2.48 | -17.30 | -82.36 |
| EPS Diluted Continuous Ops | -1.45 | -1.98 | -2.48 | -15.65 | -67.96 |
| EPS Diluted Before Non-Recurring Items | -1.45 | -1.98 | -2.48 | -17.30 | N/A |
| EBITDA(a) | $-94,924 | $-91,228 | $-71,320 | $-41,232 | $-10,145 |